1 – 6 of 6
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010) : a prospective, intergroup, open-label, single-arm clinical trial
(
- Contribution to journal › Article
-
Mark
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
(
- Contribution to journal › Article
- 2014
-
Mark
Comparison of MRD monitoring by IG/TR rearrangement and BCR/ABL1 transcript in PH+ pediatric acute lymphoblastic leukemia patients treated with imatinib in the EsPhALL study
(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia
(
- Contribution to journal › Article
- 2010
-
Mark
Oligoclonal Origin Of Functionally Distinct Leukemic Stem Cells In Infant Acute Lymphoblastic Leukemia
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+BM Subsets Initiate Leukemia in NOD/SCID Mice
(
- Contribution to journal › Published meeting abstract